Planet Labs PBC's high P/S ratio is backed by strong future revenue projections. Investors see a slim chance of revenue decrease, supporting the high ratio. Provided analysts' predictions are accurate, these robust revenue forecasts should sustain the share price.
The insider transactions at Planet Labs PBC indicate a bullish sentiment. Despite the shares currently trading below their purchase price, insiders have not sold any units over the last year, reflecting their confidence in the company's future prospects.
$ガイドワイア ソフトウェア(GWRE.US)$— Shares slipped 2% in extended trading after the insurance software company reported that revenue for the fiscal first quarter would miss analysts' estimates. Guidewire is calling for revenue of $197 million to $202 million, while analysts polled by FactSet anticipated $212.5 million. $スマートシート A(SMAR.US)$— Smartsheet's stock popped 6% after the work management software company beat analyst estimates for second-quarter...
プラネット ラボズに関するコメント
$スマートシート A(SMAR.US)$ — Smartsheet's stock popped 6% after the work management software company beat analyst estimates for second-quarter...
$SpaceX(FT0002)$
$アマゾン ドット コム(AMZN.US)$
$テレサット(TSAT.US)$
$プラネット ラボズ(PL.US)$
$ロッキード マーチン(LMT.US)$
$スパイアー グローバル A(SPIR.US)$
$テスラ(TSLA.US)$
There are several companies involved in the development of satellite constellations. Here are some notable examples:
1. SpaceX (Starlink): SpaceX, led by Elon Musk, is developing the Starlink satellite constellation. It aims to provide global broadband internet coverage by deploying thousands...
In reaction to earnings/guidance:
• $プラネット ラボズ(PL.US)$ +11.3%, $コアメイン A(CNM.US)$ +6.1%, $リーガル レックスノード(RRX.US)$ +2% (reaffirms outlook), $オラクル(ORCL.US)$ +1.6%
Other news:
• $アケロ セラピューティクス(AKRO.US)$ +93.2% (reports Phase 2b HARMONY Study)
• $Akouos(AKUS.US)$ +10.3% (FDA clears IND application to initiate a Phase 1/2 first in human pediatric clinical trial of AK-OTOF)
• $カタリスト ファーマシューティカルズ(CPRX.US)$ +7.7...
まだコメントはありません